The prolonged release of oxytetracycline hydrochloride from ethylcellulose microcapsules. 1982

M S Mesiha, and A E Aboutaleb

Oxytetracycline hydrochloride microcapsules were prepared by separation of ethylcellulose from cyclohexane solution following cooling. Incomplete release was found when testing the dissolution rate in water. Interaction of the polymer with oxytetracycline was elucidated by IR spectroscopy. More release of the drug in water agreed with the diffusional model, but in acid it was more complex.

UI MeSH Term Description Entries
D010118 Oxytetracycline A TETRACYCLINE analog isolated from the actinomycete STREPTOMYCES RIMOSUS and used in a wide variety of clinical conditions. Hydroxytetracycline,Bisolvomycin,Geomycin,Oxyterracin,Oxyterracine,Oxytetracid,Oxytetracycline Anhydrous,Oxytetracycline Calcium,Oxytetracycline Dihydrate,Oxytetracycline Hydrochloride,Oxytetracycline Monohydrochloride,Oxytetracycline Sulfate (2:1),Oxytetracycline, (4a beta,5 beta,5a beta,12a beta)-Isomer,Oxytetracycline, (5 beta)-Isomer,Oxytetracycline, Anhydrous,Oxytetracycline, Calcium (1:1) Salt,Oxytetracycline, Disodium Salt, Dihydrate,Oxytetracycline, Sodium Salt,Terramycin
D010316 Particle Size Relating to the size of solids. Particle Sizes,Size, Particle,Sizes, Particle
D002214 Capsules Hard or soft soluble containers used for the oral administration of medicine. Capsule,Microcapsule,Microcapsules
D002482 Cellulose A polysaccharide with glucose units linked as in CELLOBIOSE. It is the chief constituent of plant fibers, cotton being the purest natural form of the substance. As a raw material, it forms the basis for many derivatives used in chromatography, ion exchange materials, explosives manufacturing, and pharmaceutical preparations. Alphacel,Avicel,Heweten,Polyanhydroglucuronic Acid,Rayophane,Sulfite Cellulose,alpha-Cellulose,Acid, Polyanhydroglucuronic,alpha Cellulose
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

M S Mesiha, and A E Aboutaleb
April 2010, Journal of pharmacy & bioallied sciences,
M S Mesiha, and A E Aboutaleb
January 1997, PDA journal of pharmaceutical science and technology,
M S Mesiha, and A E Aboutaleb
September 1980, Chemical & pharmaceutical bulletin,
M S Mesiha, and A E Aboutaleb
November 2002, Chemical & pharmaceutical bulletin,
M S Mesiha, and A E Aboutaleb
January 1988, Journal of microencapsulation,
M S Mesiha, and A E Aboutaleb
April 2010, Current drug delivery,
M S Mesiha, and A E Aboutaleb
March 1999, Drug development and industrial pharmacy,
Copied contents to your clipboard!